Cargando…

Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)

Ricin, a member of the A-B family of ribosome-inactivating proteins, is classified as a Select Toxin by the Centers for Disease Control and Prevention because of its potential use as a biothreat agent. In an effort to engineer therapeutics for ricin, we recently produced a collection of alpaca-deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, Cristina, Vance, David J., Eisele, Leslie E., Shoemaker, Charles B., Mantis, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053406/
https://www.ncbi.nlm.nih.gov/pubmed/24918772
http://dx.doi.org/10.1371/journal.pone.0099788
_version_ 1782320375694098432
author Herrera, Cristina
Vance, David J.
Eisele, Leslie E.
Shoemaker, Charles B.
Mantis, Nicholas J.
author_facet Herrera, Cristina
Vance, David J.
Eisele, Leslie E.
Shoemaker, Charles B.
Mantis, Nicholas J.
author_sort Herrera, Cristina
collection PubMed
description Ricin, a member of the A-B family of ribosome-inactivating proteins, is classified as a Select Toxin by the Centers for Disease Control and Prevention because of its potential use as a biothreat agent. In an effort to engineer therapeutics for ricin, we recently produced a collection of alpaca-derived, heavy-chain only antibody V(H) domains (V(H)H or “nanobody”) specific for ricin’s enzymatic (RTA) and binding (RTB) subunits. We reported that one particular RTB-specific V(H)H, RTB-B7, when covalently linked via a peptide spacer to different RTA-specific V(H)Hs, resulted in heterodimers like V(H)H D10/B7 that were capable of passively protecting mice against a lethal dose challenge with ricin. However, RTB-B7 itself, when mixed with ricin at a 1∶10 toxin:antibody ratio did not afford any protection in vivo, even though it had demonstrable toxin-neutralizing activity in vitro. To better define the specific attributes of antibodies associated with ricin neutralization in vitro and in vivo, we undertook a more thorough characterization of RTB-B7. We report that RTB-B7, even at 100-fold molar excess (toxin:antibody) was unable to alter the toxicity of ricin in a mouse model. On the other hand, in two well-established cytotoxicity assays, RTB-B7 neutralized ricin with a 50% inhibitory concentration (IC(50)) that was equivalent to that of 24B11, a well-characterized and potent RTB-specific murine monoclonal antibody. In fact, RTB-B7 and 24B11 were virtually identical when compared across a series of in vitro assays, including adherence to and neutralization of ricin after the toxin was pre-bound to cell surface receptors. RTB-B7 differed from both 24B11 and V(H)H D10/B7 in that it was relatively less effective at blocking ricin attachment to receptors on host cells and was not able to form high molecular weight toxin:antibody complexes in solution. Whether either of these activities is important in ricin toxin neutralizing activity in vivo remains to be determined.
format Online
Article
Text
id pubmed-4053406
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40534062014-06-18 Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB) Herrera, Cristina Vance, David J. Eisele, Leslie E. Shoemaker, Charles B. Mantis, Nicholas J. PLoS One Research Article Ricin, a member of the A-B family of ribosome-inactivating proteins, is classified as a Select Toxin by the Centers for Disease Control and Prevention because of its potential use as a biothreat agent. In an effort to engineer therapeutics for ricin, we recently produced a collection of alpaca-derived, heavy-chain only antibody V(H) domains (V(H)H or “nanobody”) specific for ricin’s enzymatic (RTA) and binding (RTB) subunits. We reported that one particular RTB-specific V(H)H, RTB-B7, when covalently linked via a peptide spacer to different RTA-specific V(H)Hs, resulted in heterodimers like V(H)H D10/B7 that were capable of passively protecting mice against a lethal dose challenge with ricin. However, RTB-B7 itself, when mixed with ricin at a 1∶10 toxin:antibody ratio did not afford any protection in vivo, even though it had demonstrable toxin-neutralizing activity in vitro. To better define the specific attributes of antibodies associated with ricin neutralization in vitro and in vivo, we undertook a more thorough characterization of RTB-B7. We report that RTB-B7, even at 100-fold molar excess (toxin:antibody) was unable to alter the toxicity of ricin in a mouse model. On the other hand, in two well-established cytotoxicity assays, RTB-B7 neutralized ricin with a 50% inhibitory concentration (IC(50)) that was equivalent to that of 24B11, a well-characterized and potent RTB-specific murine monoclonal antibody. In fact, RTB-B7 and 24B11 were virtually identical when compared across a series of in vitro assays, including adherence to and neutralization of ricin after the toxin was pre-bound to cell surface receptors. RTB-B7 differed from both 24B11 and V(H)H D10/B7 in that it was relatively less effective at blocking ricin attachment to receptors on host cells and was not able to form high molecular weight toxin:antibody complexes in solution. Whether either of these activities is important in ricin toxin neutralizing activity in vivo remains to be determined. Public Library of Science 2014-06-11 /pmc/articles/PMC4053406/ /pubmed/24918772 http://dx.doi.org/10.1371/journal.pone.0099788 Text en © 2014 Herrera et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Herrera, Cristina
Vance, David J.
Eisele, Leslie E.
Shoemaker, Charles B.
Mantis, Nicholas J.
Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)
title Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)
title_full Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)
title_fullStr Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)
title_full_unstemmed Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)
title_short Differential Neutralizing Activities of a Single Domain Camelid Antibody (V(H)H) Specific for Ricin Toxin’s Binding Subunit (RTB)
title_sort differential neutralizing activities of a single domain camelid antibody (v(h)h) specific for ricin toxin’s binding subunit (rtb)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053406/
https://www.ncbi.nlm.nih.gov/pubmed/24918772
http://dx.doi.org/10.1371/journal.pone.0099788
work_keys_str_mv AT herreracristina differentialneutralizingactivitiesofasingledomaincamelidantibodyvhhspecificforricintoxinsbindingsubunitrtb
AT vancedavidj differentialneutralizingactivitiesofasingledomaincamelidantibodyvhhspecificforricintoxinsbindingsubunitrtb
AT eiselelesliee differentialneutralizingactivitiesofasingledomaincamelidantibodyvhhspecificforricintoxinsbindingsubunitrtb
AT shoemakercharlesb differentialneutralizingactivitiesofasingledomaincamelidantibodyvhhspecificforricintoxinsbindingsubunitrtb
AT mantisnicholasj differentialneutralizingactivitiesofasingledomaincamelidantibodyvhhspecificforricintoxinsbindingsubunitrtb